New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

about

Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance.

P2860

Q37093999-041466E4-71B6-4D37-96B7-B55802A0399D

P2860

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

Item

http://www.wikidata.org/entity/Q43084659

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

@en

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

@nl

type

Item

label

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

@en

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

@nl

prefLabel

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

@en

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

@nl

P1476

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

@en

P2093

Wei Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Perspectives on a combined test of multi serum biomarkers in China: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage

Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china

Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation

Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for human hepatocellular carcinoma.

Omics-based nanomedicine: the future of personalized oncology.

The '-omics' revolution and oesophageal adenocarcinoma.

Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines.

Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan.

Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.

Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.

P304

639-640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3978/J.ISSN.1000-9604.2014.11.07

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoshinori Inagaki

Peipei Song

Norihiro Kokudo

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25561758

http://www.w3.org/2001/XMLSchema#string

P932

4279209

http://www.w3.org/2001/XMLSchema#string

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

about

P2860

P2860

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932